|
ZC3H8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.986200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.146200E-01 |
| Normal-vs-Stage2 |
8.164600E-01 |
| Normal-vs-Stage3 |
1.322380E-02 |
| Normal-vs-Stage4 |
2.219600E-01 |
| Stage1-vs-Stage2 |
8.481200E-01 |
| Stage1-vs-Stage3 |
7.836300E-03 |
| Stage1-vs-Stage4 |
2.289200E-01 |
| Stage2-vs-Stage3 |
1.267010E-01 |
| Stage2-vs-Stage4 |
4.542600E-01 |
| Stage3-vs-Stage4 |
5.119200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.463020E-01 |
| Normal-vs-AfricanAmerican |
4.227800E-01 |
| Normal-vs-Asian |
6.240900E-03 |
| Caucasian-vs-AfricanAmerican |
9.995800E-01 |
| Caucasian-vs-Asian |
3.384200E-02 |
| AfricanAmerican-vs-Asian |
4.643900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.038000E-01 |
| Normal-vs-Female |
3.479600E-01 |
| Male-vs-Female |
7.826400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.535200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.296800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.060190E-01 |
| Normal-vs-Age(81-100Yrs) |
1.886580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.124000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.047600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.364200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.225200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.186400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.315400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.310300E-02 |
| Normal-vs-Grade 2 |
8.659200E-01 |
| Normal-vs-Grade 3 |
5.851600E-02 |
| Normal-vs-Grade 4 |
4.974000E-02 |
| Grade 1-vs-Grade 2 |
2.582000E-01 |
| Grade 1-vs-Grade 3 |
6.302000E-02 |
| Grade 1-vs-Grade 4 |
9.840300E-03 |
| Grade 2-vs-Grade 3 |
2.987500E-02 |
| Grade 2-vs-Grade 4 |
3.602500E-02 |
| Grade 3-vs-Grade 4 |
4.101400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.118190E-01 |
| Normal-vs-ccB subtype |
1.019830E-03 |
| ccA subtype-vs-ccB subtype |
4.70090000037615E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.966000E-01 |
| Normal-vs-N1 |
2.510200E-01 |
| N0-vs-N1 |
4.579400E-01 |
|
|
